Without Strattera, Will Lilly Merge?
Lilly may be pushed to reconsider doing a major merger or acquisition as it faces unexpected generic competition for its key ADHD drug.
Lilly may be pushed to reconsider doing a major merger or acquisition as it faces unexpected generic competition for its key ADHD drug.